![Ethyl 5-methyl-8-nitro-6-oxo-5,6-dihydro-4H-benzo-[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate](https://static.cymitquimica.com/products/3D/img/JDA37797.png "Cliquez pour agrandir")
Ethyl 5-methyl-8-nitro-6-oxo-5,6-dihydro-4H-benzo-[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate
CAS : 84377-97-9
Ref. 3D-JDA37797
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté |
Informations sur le produit
Nom :
Ethyl 5-methyl-8-nitro-6-oxo-5,6-dihydro-4H-benzo-[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate
Synonymes :
- 5,6-Dihydro-5-methyl-8-nitro-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine-3-carboxylic acid ethyl ester
- Ro 15-2344
Description :
Ethyl 5-methyl-8-nitro-6-oxo-5,6-dihydro-4H-benzo-[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate is a drug that has been shown to be effective in treating epileptic seizures. This compound binds to the benzodiazepine receptor and activates it by increasing the concentration of gamma aminobutyric acid (GABA) in the brain. The activity of this drug has been studied in both human and animal studies. It is a radiolabeled compound that has been used as an unlabeled ligand for positron emission tomography (PET).
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
330.3 g/mol
Formule :
C15H14N4O5
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
